UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

1037-P: Efficacy and Safety of Fast-Acting Insulin Aspart in Adults with T2D with Different Insulin Requirements

Diabetes (New York, N.Y.), 2020-06, Vol.69 (Supplement_1)

2020

Volltextzugriff (PDF)

147-OR: DUAL VIII: Significantly Longer Time to Treatment Intensification with Insulin Degludec/Liraglutide (IDegLira) vs. Insulin Glargine (IGlar U100) in a 104-Week (Wk) Randomized Trial Mirroring Clinical Practice

Diabetes (New York, N.Y.), 2019-06, Vol.68 (Supplement_1)

2019

Volltextzugriff (PDF)

2009 SIPREC Consensus Document — Executive Summary: Cardiovascular Prevention in Subjects with Impaired Fasting Glucose or Impaired Glucose Tolerance

High blood pressure & cardiovascular prevention, 2010-12, Vol.17 (4), p.237-247

2010

Volltextzugriff (PDF)

2009 SIPREC Consensus Document — Executive Summary

High blood pressure & cardiovascular prevention, 2010-12, Vol.17 (4), p.237-247

2010

Volltextzugriff (PDF)

3′-UTR OLR1/LOX-1 gene polymorphism and endothelial dysfunction: molecular and vascular data in never-treated hypertensive patients

Internal and emergency medicine, 2014-04, Vol.9 (3), p.273-281

2014

Volltextzugriff (PDF)

498 Oxidative stress and left ventricular performance in patients according to different glycometabolic phenotypes

European heart journal supplements, 2021-12, Vol.23 (Supplement_G)

2021

Volltextzugriff (PDF)

The −866A/A Genotype in the Promoter of the Human Uncoupling Protein 2 Gene Is Associated With Insulin Resistance and Increased Risk of Type 2 Diabetes

Diabetes (New York, N.Y.), 2004-07, Vol.53 (7), p.1905-1910

2004

Volltextzugriff (PDF)

91 METABOLIC AND CARDIAC MORPHO-FUNCTIONAL IMPROVEMENTS AFTER PCSK9 INHIBITORS ADMINISTRATION

European heart journal supplements, 2022-12, Vol.24 (Supplement_K)

2022

Volltextzugriff (PDF)

93 EFFECT OF SACUBITRIL/VALSARTAN ON ENDOTHELIAL DYSFUNCTION AND ARTERIAL STIFFNESS IN PATIENTS WITH CHRONIC HEART FAILURE

European heart journal supplements, 2022-12, Vol.24 (Supplement_K)

2022

Volltextzugriff (PDF)

Abstract MP051: A Novel Genetic Locus for Coronary Heart Disease in Type 2 Diabetes

Circulation (New York, N.Y.), 2012-03, Vol.125 (suppl_10)

2012

Volltextzugriff (PDF)

Additive Effect of Non-Alcoholic Fatty Liver Disease on Metabolic Syndrome-Related Endothelial Dysfunction in Hypertensive Patients

International journal of molecular sciences, 2016-04, Vol.17 (4), p.456-456

2016

Volltextzugriff (PDF)

Alkaline phosphatase affects renal function in never-treated hypertensive patients: effect modification by age

Scientific reports, 2020-06, Vol.10 (1), p.9847-9847, Article 9847

2020

Volltextzugriff (PDF)

Altered expression of the two naturally occurring human insulin receptor variants in isolated adipocytes of non-insulin-dependent diabetes mellitus patients

Biochemical and biophysical research communications, 1991-12, Vol.181 (3), p.1419-1424

1991

Volltextzugriff (PDF)

Altered Insulin Receptor Signalling and [beta]-Cell Cycle Dynamics in Type 2 Diabetes Mellitus

PloS one, 2011-11, Vol.6 (11), p.e28050

2011

Volltextzugriff (PDF)

Altered insulin receptor signalling and β-cell cycle dynamics in type 2 diabetes mellitus

PloS one, 2011-11, Vol.6 (11), p.e28050-e28050

2011

Volltextzugriff (PDF)

Androgens increase insulin receptor mRNA levels, insulin binding, and insulin responsiveness in HEp-2 larynx carcinoma cells

Molecular and cellular endocrinology, 1992-07, Vol.86 (1), p.111-118

1992

Volltextzugriff (PDF)

Angiotensin (1-7) counteracts the negative effect of angiotensin II on insulin signalling in HUVECs

Cardiovascular research, 2013-07, Vol.99 (1), p.129-136

2013

Volltextzugriff (PDF)

Angiotensin II Impairs the Insulin Signaling Pathway Promoting Production of Nitric Oxide by Inducing Phosphorylation of Insulin Receptor Substrate-1 on Ser 312 and Ser 616 in Human Umbilical Vein Endothelial Cells

Circulation research, 2004-05, Vol.94 (9), p.1211-1218

2004

Volltextzugriff (PDF)

Angiotensin II Impairs the Insulin Signaling Pathway Promoting Production of Nitric Oxide by Inducing Phosphorylation of Insulin Receptor Substrate-1 on Ser312 and Ser616 in Human Umbilical Vein Endothelial Cells

Circulation research, 2004-05, Vol.94 (9), p.1211-1218

2004

Volltextzugriff (PDF)

Angiotensin II type 1 receptor, but no type 2 receptor, interferes with the insulin-induced nitric oxide production in HUVECs

Atherosclerosis, 2011-12, Vol.219 (2), p.463-467

2011

Volltextzugriff (PDF)

Anthropometric variables accurately predict dual energy x-ray absorptiometric-derived body composition and can be used to screen for diabetes

PloS one, 2011-09, Vol.6 (9), p.e24017-e24017

2011

Volltextzugriff (PDF)

Anti-TNF therapy and plasma HDL cholesterol concentration

Atherosclerosis, 2005-10, Vol.182 (2), p.375-375

2005

Volltextzugriff (PDF)

Antiphospholipid antibodies and idiopathic infertility

Lupus, 2022-03, Vol.31 (3), p.347-353

2022

Volltextzugriff (PDF)

Apelin ameliorates TNF-α-induced reduction of glycogen synthesis in the hepatocytes through G protein-coupled receptor APJ

PloS one, 2013-02, Vol.8 (2), p.e57231

2013

Volltextzugriff (PDF)

1 – 25 von 498

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(465)
Mit Volltextzugriff
(461)

Publikationsform

Artikel
(497)
Tagungsberichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

1037-P: Efficacy and Safety of Fast-Acting Insulin Aspart in Adults with T2D with Different Insulin Requirements

147-OR: DUAL VIII: Significantly Longer Time to Treatment Intensification with Insulin Degludec/Liraglutide (IDegLira) vs. Insulin Glargine (IGlar U100) in a 104-Week (Wk) Randomized Trial Mirroring Clinical Practice

2009 SIPREC Consensus Document — Executive Summary: Cardiovascular Prevention in Subjects with Impaired Fasting Glucose or Impaired Glucose Tolerance

2009 SIPREC Consensus Document — Executive Summary

3′-UTR OLR1/LOX-1 gene polymorphism and endothelial dysfunction: molecular and vascular data in never-treated hypertensive patients

498 Oxidative stress and left ventricular performance in patients according to different glycometabolic phenotypes

The −866A/A Genotype in the Promoter of the Human Uncoupling Protein 2 Gene Is Associated With Insulin Resistance and Increased Risk of Type 2 Diabetes

91 METABOLIC AND CARDIAC MORPHO-FUNCTIONAL IMPROVEMENTS AFTER PCSK9 INHIBITORS ADMINISTRATION

93 EFFECT OF SACUBITRIL/VALSARTAN ON ENDOTHELIAL DYSFUNCTION AND ARTERIAL STIFFNESS IN PATIENTS WITH CHRONIC HEART FAILURE

Abstract MP051: A Novel Genetic Locus for Coronary Heart Disease in Type 2 Diabetes

Accuracy of 1-Hour Plasma Glucose During the Oral Glucose Tolerance Test in Diagnosis of Type 2 Diabetes in Adults: A Meta-analysis

Additive Effect of Non-Alcoholic Fatty Liver Disease on Metabolic Syndrome-Related Endothelial Dysfunction in Hypertensive Patients

Alkaline phosphatase affects renal function in never-treated hypertensive patients: effect modification by age

Altered expression of the two naturally occurring human insulin receptor variants in isolated adipocytes of non-insulin-dependent diabetes mellitus patients

Altered Insulin Receptor Signalling and [beta]-Cell Cycle Dynamics in Type 2 Diabetes Mellitus

Altered insulin receptor signalling and β-cell cycle dynamics in type 2 diabetes mellitus

Androgens increase insulin receptor mRNA levels, insulin binding, and insulin responsiveness in HEp-2 larynx carcinoma cells

Angiotensin (1-7) counteracts the negative effect of angiotensin II on insulin signalling in HUVECs

Angiotensin II Impairs the Insulin Signaling Pathway Promoting Production of Nitric Oxide by Inducing Phosphorylation of Insulin Receptor Substrate-1 on Ser 312 and Ser 616 in Human Umbilical Vein Endothelial Cells

Angiotensin II Impairs the Insulin Signaling Pathway Promoting Production of Nitric Oxide by Inducing Phosphorylation of Insulin Receptor Substrate-1 on Ser312 and Ser616 in Human Umbilical Vein Endothelial Cells

Angiotensin II type 1 receptor, but no type 2 receptor, interferes with the insulin-induced nitric oxide production in HUVECs

Anthropometric variables accurately predict dual energy x-ray absorptiometric-derived body composition and can be used to screen for diabetes

Anti-TNF therapy and plasma HDL cholesterol concentration

Antiphospholipid antibodies and idiopathic infertility

Apelin ameliorates TNF-α-induced reduction of glycogen synthesis in the hepatocytes through G protein-coupled receptor APJ

Suchergebnisse filtern